Skip to content

Exploring musculoskeletal Complaints in Visually Impaired Patients: A Physiotherapeutic Perspective

Exploring musculoskeletal Complaints in Visually Impaired Patients: A Physiotherapeutic Perspective

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035125
Enrollment
90
Registered
2024-09-30
Start date
2023-04-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H00-H59

Interventions

Group 1: People with visual impairments in inpatient rehabilitation with a duration of visual impairment of less than 1 year. Group 2: People with visual impairments in inpatient rehabilitation with a

Sponsors

Regiomed Rehabilitationsklinik Masserberg
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Willingness to participate - Primary ophthalmological admission diagnosis

Exclusion criteria

Exclusion criteria: - Surgical procedures in the cervical spine area - Systemic diseases (e.g., MS, ALS, rheumatoid arthritis) - Dizziness, tinnitus - Diagnosed temporomandibular joint disorder (CMD) - Insufficient German language skills - Combined hearing and visual impairment

Design outcomes

Primary

MeasureTime frame
Subjective pain assessment using the Numeric Pain Rating Scale. Collected once at the beginning of rehabilitation.

Secondary

MeasureTime frame
Neck Disability Index (NDI) Falls Efficacy Scale International (FESI) National Eye Institute Visual Function Questionnaire (NEIVFQ-25) Fullerton Advanced Balance Scale (FABS) Motor Control Short Screening All secondary endpoints were collected once at the beginning of inpatient rehabilitation

Countries

Germany

Contacts

Public ContactBernd Brechtelsbauer

Regiomed Rehabilitationsklinik Masserberg

bernd.brechtelsbauer@regiomed-kliniken.de036870 81590

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 18, 2026